IRCT201201028597N1
Completed
未知
Comparison between ciclesonide and fluticasone in patients with mild persistant asthma asthma
Massih Daneshvari hospital0 sites356 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Asthma.
- Sponsor
- Massih Daneshvari hospital
- Enrollment
- 356
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Ladies and gentlemen between 12 and 75 years as the definitive diagnosis of asthma is confirmed as mild persistent asthma: (Symptoms more than two days per week but less than daily incidence, symptoms at night more than two nights in month but less thatn every night, FEV1 \= 80% predicted, FEV1 Variability% 20 \-% 30 and the use of B2 agonists short acting more than two days a week but less than daily).
- •Exclusion criteria: A) Having any of the criteria for moderate persistent asthma B) Pregnancy \- Breastfeeding C) sensitivity to corticosteroids D) other lung diseases like COPD E) use of systemic corticosteroids in acute asthma attacks during two months before the run in period
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Effect of Ciclesonide (320 µg/day) vs. Fluticasone Propionate (375 µg/day) vs. Placebo on Short-term Linear Growth Rate and HPA-axis Function in Prepubertal Children with Mild AsthmaA double-blind, double-dummy, placebo-controlled, randomized, 3 period cross-over studyasthma bronchialeMedDRA version: 5.1Level: lltClassification code 10003553EUCTR2005-001386-34-DKALTANA Pharma AG
Completed
Not Applicable
Comparative study of high-dose ciclesonide and fluticasone on small airway in asthmaticsasthmaJPRN-UMIN000002665Kurume University School of Medicine18
Completed
Not Applicable
Comparison of clinical efficacy between fluticasone propionate/ formoterol (FFC) and fluticasone furoate/ vilanterol (VFC) in patients with asthmaJPRN-UMIN000031039Ikeda Clinic24
Not yet recruiting
Phase 3
Comparison of Fluticasone and Budesonide Intranasal Corticosteroid in Terms of Taste, Sensation, Delivery and Adherence in Children Aged 6-14 Years with Allergic Rhinitis (Hayfever)Allergic rhinitisInflammatory and Immune System - AllergiesACTRN12613001148763Mater Health Services110
Completed
Phase 3
Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)AsthmaNCT00163358AstraZeneca630